| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |